Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study

INTRODUCTION: Once-weekly (OW) glucagon-like peptide 1 receptor agonist (GLP-1RA) semaglutide has been shown to have a more potent glycated hemoglobin (HbA1c)-lowering effect than other oral hypoglycemic agents and existing GLP-1RAs in global randomized controlled trials. The study aim was to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Hodaka, Yoshida, Masashi, Suzuki, Daisuke, Funazaki, Shunsuke, Nagashima, Shuichi, Masahiko, Kimura, Kiyoshi, Otsuka, Hara, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500122/
https://www.ncbi.nlm.nih.gov/pubmed/36006593
http://dx.doi.org/10.1007/s13300-022-01313-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500122/
https://www.ncbi.nlm.nih.gov/pubmed/36006593
http://dx.doi.org/10.1007/s13300-022-01313-0

Ejemplares similares